A 10 mg total vial is a research-practical size: enough for substantial protocols, small enough to consume within the reconstituted-stability window for most research designs
Once reconstituted, the solution should be kept refrigerated and used within a short period
In a subsequent prospective cohort, liraglutide not only improved metabolic parameters but also demonstrated immunomodulatory effects, with a significant reduction in circulating T-cell populations, particularly T cells, which are known to play a key role in PsO pathogenesis by producing IL17 and IL22 ( Successive case reports confirmed the beneficial effects of liraglutide in obese PsO patients without T2DM (52), and a subsequent trial demonstrated marked improvements in PsO symptoms within a few days of treatment, regardless of significant weight loss (50), a result which was later confirmed in other studies (53, 54)
Y.HsuC.-C.et al (2024)
2b and c)
While its long-term safety and efficacy are still under investigation, the Phase II results provide compelling evidence that this triple agonist could revolutionize the way we approach obesity and its associated health risks